Tafinlar 50 MG Oral Capsule

RxCUI: 1425228
RxNorm name: Tafinlar 50 MG Oral Capsule
Display name: Tafinlar 50 MG Oral Capsule
Full name: Tafinlar 50 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tafinlar	DABRAFENIB	Novartis Pharmaceuticals Corporation	fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	2026-05-20	Warnings, Adverse reactions	Exact identifier rxcui: 1425228

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	Tafinlar 50 MG Oral Capsule	PSN	37	These highlights do not include all the information needed to use TAFINLAR safely and effectively. See full prescribing information for TAFINLAR. TAFINLAR ® (dabrafenib) capsules, for oral use TAFINLAR ® (dabrafenib) tablets for oral suspension Initial U.S. Approval: 2013	20260520
fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	Tafinlar 50 MG Oral Capsule	SY	37	These highlights do not include all the information needed to use TAFINLAR safely and effectively. See full prescribing information for TAFINLAR. TAFINLAR ® (dabrafenib) capsules, for oral use TAFINLAR ® (dabrafenib) tablets for oral suspension Initial U.S. Approval: 2013	20260520
fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	Tafinlar 50 MG (as dabrafenib mesylate 59.25 MG) Oral Capsule	SY	37	These highlights do not include all the information needed to use TAFINLAR safely and effectively. See full prescribing information for TAFINLAR. TAFINLAR ® (dabrafenib) capsules, for oral use TAFINLAR ® (dabrafenib) tablets for oral suspension Initial U.S. Approval: 2013	20260520
fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	dabrafenib 50 MG Oral Capsule [Tafinlar]	SBD	37	These highlights do not include all the information needed to use TAFINLAR safely and effectively. See full prescribing information for TAFINLAR. TAFINLAR ® (dabrafenib) capsules, for oral use TAFINLAR ® (dabrafenib) tablets for oral suspension Initial U.S. Approval: 2013	20260520